𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nongenomic glucocorticoid signaling: New targets for immunosuppressive therapy?

✍ Scribed by J. Leonard M. Schoneveld; Ruth D. Fritsch-Stork; Johannes W. J. Bijlsma


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
119 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Signalling pathways and the host-parasit
✍ Hong You; Geoffrey N. Gobert; Malcolm K. Jones; Wenbao Zhang; Donald P. McManus πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 310 KB

## Abstract A better understanding of how schistosomes exploit host nutrients, neuro‐endocrine hormones and signalling pathways for growth, development and maturation may provide new insights for improved interventions in the control of schistosomiasis. This paper describes recent advances in the i

Signalling pathways and the host-parasit
✍ Hong You; Geoffrey N. Gobert; Malcolm K. Jones; Wenbao Zhang; Donald P. McManus πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 24 KB

In the above article, we -the authors -described recent advances in the identification and characterisation of schistosome tyrosine kinase and signalling pathways, notably the potential intervention value of insulin signalling in schistosomes. For greater completeness of relevant references, we woul

Targeting of a hydrophilic photosensitiz
✍ Maarten B. Vrouenraets; Gerard W.M. Visser; Christophe Loup; Bernard Meunier; Ma πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 140 KB πŸ‘ 2 views

Coupling of photosensitizers to tumor-selective monoclonal antibodies (MAbs) is an attractive option for improving the selectivity of photodynamic therapy (PDT). For this purpose, hydrophilic sensitizers would be most suitable because of their solubility in water. However, such sensitizers are known